Table III.
Univariable analysis of factors associated with pre-test cancer genetics knowledge
| Estimate | 95% CI | p-value | |
|---|---|---|---|
| Site* | |||
| Site 1 | REF | REF | — |
| Site 2 | 0.0 | (−1.20,1.27) | 0.959 |
| Age | |||
| + 10 years | −0.3 | (−1.02,0.50) | 0.504 |
| Prostate Cancer | |||
| Yes | −0.8 | (−2.07,0.41) | 0.187 |
| No | REF | REF | — |
| Family History | |||
| Yes | 2.3 | (−0.16,4.77) | 0.067 |
| No | REF | REF | — |
| HCS | |||
| Yes | 1.7 | (0.50,2.93) | 0.006 |
| No | REF | REF | — |
| Education | |||
| Less than high school | REF | REF | – |
| HS/GED or Vocational/Technical School | −0.8 | (−7.44,5.82) | 0.808 |
| Some College/Associate’s Degree | −0.7 | (−7.31,5.98) | 0.843 |
| Bachelor’s Degree or higher | 0.1 | (−6.35,6.59) | 0.971 |
| Literacy | |||
| + 1 point | 0.3 | (−0.55,1.18) | 0.471 |
| Numeracy | |||
| + 1 point | 0.8 | (0.11,1.55) | 0.025 |
*
Site 1 provided pretest counseling with a video + handout. Post-test disclosure was in-person for men with a mutation and by phone for men with a variant of uncertain significance or negative results. Site 2 provided pretest counseling and post-test disclosure in-person or by telehealth.